Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?
Chau Quang, Amy W. Chung, Ian H. Frazer, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 815-825
Closed Access | Times Cited: 19

Showing 19 citing articles:

Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?
Giovanna Milano, Giovanni Guarducci, Nicola Nante, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1060-1060
Open Access | Times Cited: 27
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
Fengcai Zhu, Guohua Zhong, Weijin Huang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1313-1322
Closed Access | Times Cited: 16
Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes
Emmanuel Dollinger, Jenny E. Hernandez‐Davies, Jiin Felgner, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
Scientific approaches to defining HPV vaccine‐induced protective immunity
Matti Lehtinen, Pierre Van Damme, Simon Beddows, et al.
International Journal of Cancer (2025)
Open Access
Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine
Chau Quang, J. L. Anderson, Fiona M. Russell, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
Yuemei Hu, Zhaofeng Bi, Ya Zheng, et al.
Science Bulletin (2023) Vol. 68, Iss. 20, pp. 2448-2455
Open Access | Times Cited: 8
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Unravelling the Impact of Human Papillomavirus (HPV): A Comprehensive Exploration of its Role in Cancer Progression and Global Health Challenges
Yashraj Potale, Yash K Kasat, Ankit Kumar, et al.
BIO Web of Conferences (2024) Vol. 86, pp. 01029-01029
Open Access | Times Cited: 1
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
Kahlio Mader, Lynn B. Dustin
Antibodies (2024) Vol. 13, Iss. 2, pp. 28-28
Open Access | Times Cited: 1
Beyond bnAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-neutralising Antibodies in Viral Infection
Kahlio Mader, Lynn B. Dustin
(2024)
Open Access | Times Cited: 1
Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies
Chau Quang, Amy W. Chung, Troy J. Kemp, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Closed Access | Times Cited: 1
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study
Penelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Editorial: HPV natural history, immunological responses and vaccination strategies: challenges and opportunities
Zheng Quan Toh, Fanghui Zhao, Lei Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access
The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination
Wanying Bao, Xinlin He, Yue Huang, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 956-956
Open Access
Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies
Ximing Hu, Yueling Chen, W.J. Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access
Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses
Lívia Zignago Moreira dos Santos, Camila Cristina Martini Rodrigues, Karina Takesaki Miyaji, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Target Policy Profile (TPoP)
Shawn Dolley, Dan Hartman, Thea Norman
(2023)
Open Access | Times Cited: 1
Actualización en el diagnóstico y manejo del virus del papiloma humano como prevención para el cáncer cervicouterino.
Erick Sebastián Mejia-Zhicay, Lauro Hernán Mejía-Campoverde
MQRInvestigar (2023) Vol. 7, Iss. 3, pp. 3282-3312
Open Access
Human papillomavirus infection associated with cervical cancer and other malignancies
Dirce Sakauchi, Aurora M. Cianciarullo
GSC Biological and Pharmaceutical Sciences (2023) Vol. 25, Iss. 1, pp. 164-177
Open Access
Page 1

Scroll to top